Proteomics
HBM contact: Dr Ivo Staijen, Dr Chandra Leo
Company status: public
Seer’s novel
Proteograph™ platform allows for the generation of proteomic information with
high accuracy at a scale and speed not previously possible, complementing
genomic and other health information, with a goal of enabling breakthroughs in
the most challenging research and clinical problems, such as early disease
detection.